Sign in

CIK 0000882796

  • Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
621413174
Phone
+1 919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-11-18 Babu Yarlagadda S Senior VP - Drug Discovery Purchase +25,000 $1.45 $36K 155,587
2019-11-18 ASELAGE STEVE Director Purchase +15,000 $1.45 $22K 21,672
2019-09-20 Thackray Helen M. Director Grant or award · Non-Qualified Stock Option +40,000 40,000
2019-09-01 HEGGIE THERESA Director Grant or award +1,672 $2.99 $5K 1,672
2019-09-01 ASELAGE STEVE Director Grant or award +1,672 $2.99 $5K 6,672
2019-09-01 Hutson Nancy J Director Grant or award +3,344 $2.99 $10K 43,046
2019-09-01 INGRAM ROBERT ALEXANDER Director Grant or award +6,270 $2.99 $19K 28,088
2019-07-01 Sniecinski Megan Chief Business Officer Grant or award · Emp. Stock Option (Right to Buy) +500,000 500,000
2019-05-29 LEE KENNETH B JR Director Grant or award · Automatic Stock Option Grant +30,000 30,000
2019-05-29 INGRAM ROBERT ALEXANDER Director Grant or award · Automatic Stock Option Grant +30,000 30,000
2019-05-29 Hutson Nancy J Director Grant or award · Automatic Stock Option Grant +30,000 30,000
2019-05-29 HEGGIE THERESA Director Grant or award · Automatic Stock Option Grant +30,000 30,000
2019-05-29 ASELAGE STEVE Director Grant or award · Automatic Stock Option Grant +30,000 30,000
2019-05-29 ABERCROMBIE GEORGE B Director Grant or award · Automatic Stock Option Grant +30,000 30,000
2019-05-22 ASELAGE STEVE Director Purchase +3,000 $3.57 $11K 5,000
2019-05-17 STAAB THOMAS R II Senior Vice President and CFO Sale −2,500 $7.45 $19K 125,176
2019-05-16 STAAB THOMAS R II Senior Vice President and CFO Option exercise +4,750 $1.42 $7K 134,926
2019-05-16 STAAB THOMAS R II Senior Vice President and CFO Sale −7,250 $7.72 $56K 127,676
2019-05-16 STAAB THOMAS R II Senior Vice President and CFO Option exercise · Emp. Stock Option (Right to Buy) −4,750 61,000
2019-05-15 STAAB THOMAS R II Senior Vice President and CFO Option exercise +4,750 $1.42 $7K 137,426

Page 28 of 38 · 750 trades